Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,537
datasets available to search
ShareScore release 0.9.0
Dataset results
8,537 results for “Openness”
Immediate Implants Inserted Through Open Flap, Open Flap and Bone Grafting and Flapless Techniques
ClinicalTrials.gov study NCT03001752. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Post-surgical Delirium in Patients Undergoing Open Heart Surgery.
ClinicalTrials.gov study NCT03806413. IPD Sharing: NO. Countries: 0. Publications: 1.
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
ClinicalTrials.gov study NCT01027949. IPD Sharing: NO. Countries: 20. Publications: 0.
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
ClinicalTrials.gov study NCT04529850. IPD Sharing: NO. Countries: 6. Publications: 0.
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers
ClinicalTrials.gov study NCT01767103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
ClinicalTrials.gov study NCT00465088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect
ClinicalTrials.gov study NCT03028103. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT04810754. IPD Sharing: Not stated. Countries: 0. Publications: 2.
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
ClinicalTrials.gov study NCT05214794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Extension Study of GSK1605786A
ClinicalTrials.gov study NCT01318993. IPD Sharing: Not stated. Countries: 31. Publications: 0.
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05769777. IPD Sharing: YES. Countries: 25. Publications: 0.
A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients
ClinicalTrials.gov study NCT05486091. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label Pilot Study of Apremilast in Treatment of Rosacea
ClinicalTrials.gov study NCT01045551. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT05913232. IPD Sharing: NO. Countries: 1. Publications: 0.
DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT01343082. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
ClinicalTrials.gov study NCT00806221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M
ClinicalTrials.gov study NCT02972333. IPD Sharing: NO. Countries: 0. Publications: 1.
Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6
ClinicalTrials.gov study NCT03858894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
ClinicalTrials.gov study NCT01454531. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
ClinicalTrials.gov study NCT05061719. IPD Sharing: NO. Countries: 11. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.